• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 5th July 2019

OHE at the 2019 International Health Economics Association (iHEA) World Congress

Meet some of the OHE team at the International Health Economics Association (iHEA) 2019 World Congress in Basel, 13-17 July. Meet some of the OHE team at the International Health Economics Association (iHEA) 2019 World Congress in Basel, 13-17 July.…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

Meet some of the OHE team at the International Health Economics Association (iHEA) 2019 World Congress in Basel, 13-17 July.

Meet some of the OHE team at the International Health Economics Association (iHEA) 2019 World Congress in Basel, 13-17 July.

The 2019 iHEA World Congress will take place from 13th to 17th July in Basel, Switzerland. Adrian Towse, Graham Cookson, Koonal Shah, Mikel Berdud, and Olga Rozanova will be attending to present work from some of OHE’s projects.

 

Understanding Shortages in the UK Generics Market

In this session, Adrian will unpick the various factors using data on concessionary price increases, trends in Category M and W prices, and interviews with relevant stakeholders. The study explores whether there is a trade-off between the “static” objective of keeping prices low and the “dynamic” objective of obtaining security of supply over time and, if so, which policies are likely to achieve the optimal balance.

Role Substitution, Skill Mix and Provider Efficiency and Effectiveness: Lessons from NHS Maternity Services

Graham will participate in an organised session on Monday July 15th 2019 -from 13:30 – 15:00. In this session he will present his paper with his co-author Ioannis Laliotis from the London School of Economics. The paper revisits the relationship between workforce and maternity outcomes in the English NHS in an attempt to contribute knowledge to an important policy question for which there has been a paucity of research.

Can Price-Cap Regulation Increase Drug Prices?

Olga will participate in a session entitled “Pharmaceutical Markets”. Her presentation considers potential perverse incentives of the price-cap regulation. The presentation concludes that the introduction of price-caps on generics may lead to some undesired consequences such as an increase in the price of the branded drugs and decrease in the consumer surplus. 

Staffing, Perverse Incentives and the Determinants of Caesarean Sections in the English NHS

In this oral presentation on Tuesday July 16th from 08.30-10.30, Graham, alongside Ioannis Laliotis, will present the findings of research examining the role of the maternity workforce in the incidence of caesarean sections.

Analysis of Hospital Markets

Olga will chair the session entitled “Analysis of Hospital Markets”. Presentations in this session will consider the issues concerning the quality of care, variation of hospital readmission, waiting time for hospital admission etc.

Quantifying the Life-Cycle Value of Innovative Medicines: The Case of Risperidone and Second-Generation Antipsychotics

In an oral presentation, Mikel will discuss how, and why, to quantify the life-cycle value of medicines. The research by OHE and the Swedish Institute for Health Economics (IHE) shows that the value that medicines add to society changes during the life-cycle and concludes that the long-run perspective should be taken into account by policy makers when they make price and reimbursement decisions at launch.  

Novel Approaches for Valuing Health at the End of Life

Koonal will participate in an organised session entitled ‘Scaling Everest: Moving Beyond Conventional Economic Approaches in Palliative & End-of-life Care’. His presentation will summarise empirical evidence on the valuation of health gains at the end of life and describe novel approaches for eliciting preferences in this context. Koonal’s presentation will be discussed by Helen Mason of Glasgow Caledonian University.

  • Research
  • Events

Related News

MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
  • News
  • January 2020

OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?

Read more
  • News
  • September 2019

OHE Lunchtime Seminar: Closing the ‘Know-do’ Gap for Health Systems Reform at the Policy Level

Read more
  • News
  • August 2019

OHE Lunchtime Seminar: How Do We Measure the ‘Value’ in Value-based Care?

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!